Milà Alomà, M., Salvadó, G., Gispert, J. D., Vilor Tejedor, N., Grau, O. (. R., Sala Vila, A., . . . Study, A. (2020). Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum.
Citación estilo ChicagoMilà Alomà, Marta, et al. Amyloid Beta, Tau, Synaptic, Neurodegeneration, and Glial Biomarkers in the Preclinical Stage of the Alzheimer's Continuum. 2020.
Cita MLAMilà Alomà, Marta, et al. Amyloid Beta, Tau, Synaptic, Neurodegeneration, and Glial Biomarkers in the Preclinical Stage of the Alzheimer's Continuum. 2020.
Precaución: Estas citas no son 100% exactas.